On Tuesday, the Associated Press reported that the Drug Enforcement Administration is proposing that cannabis be reclassified from Schedule I of the Controlled Substances Act, a classification that comes with steep penalties, to the less severe Schedule III, for drugs with significant medical use. If the White House Office of Management and Budget approves the decision, the DEA […] Read this story
